Distinct roles for human cytomegalovirus immediate early proteins IE1 and IE2 in the transcriptional regulation of MICA and PVR/CD155 expression

Journal of Immunology

Volumn 197, Issue 10, 2016, Pages 4066-4078

  Pignoloni, Benedetta ^a   Fionda, Cinzia ^a   Dell'Oste, Valentina ^b   Luganini, Anna ^b   Cippitelli, Marco ^a   Zingoni, Alessandra ^a   Landolfo, Santo ^b   Gribaudo, Giorgio ^b   Santoni, Angela ^a,c   Cerboni, Cristina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE RAD3; DNA DEPENDENT PROTEIN KINASE; FOSCARNET; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 1; IMMEDIATE EARLY PROTEIN 2; LYMPHOCYTE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN DNAM 1; UNCLASSIFIED DRUG; VIRUS DNA; CD226 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HLA ANTIGEN CLASS 1; IE1 PROTEIN, CYTOMEGALOVIRUS; IE2 PROTEIN, CYTOMEGALOVIRUS; KLRK1 PROTEIN, HUMAN; MHC CLASS I-RELATED CHAIN A; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; POLIOVIRUS RECEPTOR; SIGNAL PEPTIDE; T LYMPHOCYTE ANTIGEN; TRANSACTIVATOR PROTEIN; ULBP3 PROTEIN, HUMAN; VIRAL PROTEIN; VIRUS RECEPTOR;

ALLELE; ARTICLE; BINDING AFFINITY; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS INFECTION; DNA DAMAGE; DNA REPLICATION; EMBRYO; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INHIBITION KINETICS; MICA GENE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PVR GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ULBP3 GENE; UPREGULATION; VIRUS GENE; VIRUS STRAIN; CELL LINE; CYTOTOXICITY; DRUG EFFECTS; FIBROBLAST; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; VIROLOGY; VIRUS REPLICATION;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DNA REPLICATION; FIBROBLASTS; FOSCARNET; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, VIRUS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84994415884     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502527     Document Type: Article

References (81)

1. Britt, W. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325: 417-470.
2. Mocarski, E. S., T. Shenk, P. Griffiths, and R. F. Pass. 2013. Cytomegaloviruses. In Fields Virology, 6th Ed., D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, p. 1960-2014.
3. Sinzger, C., M. Digel, and G. Jahn. 2008. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 325: 63-83.
4. Boeckh, M., W. J. Murphy, and K. S. Peggs. 2015. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol. Blood Marrow Transplant. 21: 24-29.
5. Chou, S. 2015. Approach to drug-resistant cytomegalovirus in transplant recipients. Curr. Opin. Infect. Dis. 28: 293-299.
6. Eagle, R. A., and J. Trowsdale. 2007. Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 7: 737-744.
7. Champsaur, M., and L. L. Lanier. 2010. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 235: 267-285.
8. Fuchs, A., and M. Colonna. 2006. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin. Cancer Biol. 16: 359-366.
9. Cella, M., R. Presti, W. Vermi, K. Lavender, E. Turnbull, C. Ochsenbauer-Jambor, J. C. Kappes, G. Ferrari, L. Kessels, I. Williams, et al; CHAVI Clinical Core B; NIAID Center for HIV/AIDS Vaccine Immunology. 2010. Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. Eur. J. Immunol. 40: 949-954.
10. Welch, M. J., J. R. Teijaro, H. A. Lewicki, M. Colonna, and M. B. Oldstone. 2012. CD8 T cell defect of TNF-a and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection. Virology 429: 163-170.
11. Nabekura, T., M. Kanaya, A. Shibuya, G. Fu, N. R. Gascoigne, and L. L. Lanier. 2014. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 40: 225-234.
12. de Andrade, L. F., M. J. Smyth, and L. Martinet. 2014. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins. Immunol. Cell Biol. 92: 237-244.
13. Takai, Y., J. Miyoshi, W. Ikeda, and H. Ogita. 2008. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 9: 603-615.
14. Wilkinson, G. W., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, S. Llewellyn-Lacey, et al. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41: 206-212.
15. Rossini, G., C. Cerboni, A. Santoni, M. P. Landini, S. Landolfo, D. Gatti, G. Gribaudo, and S. Varani. 2012. Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm. 2012: 607276.
16. Fielding, C. A., R. Aicheler, R. J. Stanton, E. C. Wang, S. Han, S. Seirafian, J. Davies, B. P. McSharry, M. P. Weekes, P. R. Antrobus, et al. 2014. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog. 10: e1004058.
17. Seidel, E., V. T. Le, Y. Bar-On, P. Tsukerman, J. Enk, R. Yamin, N. Stein, D. Schmiedel, E. Oiknine Djian, Y. Weisblum, et al. 2015. Dynamic co-evolution of host and pathogen: HCMV downregulates the prevalent allele MICAp008 to escape elimination by NK cells. Cell Rep. 10: 968-982.
18. Castillo, J. P., and T. F. Kowalik. 2002. Human cytomegalovirus immediate early proteins and cell growth control. Gene 290: 19-34.
19. Stinski, M. F., and D. T. Petrik. 2008. Functional roles of the human cytomegalovirus essential IE86 protein. Curr. Top. Microbiol. Immunol. 325: 133-152.
20. Lang, D., and T. Stamminger. 1993. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J. Virol. 67: 323-331.
21. Malone, C. L., D. H. Vesole, and M. F. Stinski. 1990. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J. Virol. 64: 1498-1506.
22. Pizzorno, M. C., M. A. Mullen, Y. N. Chang, and G. S. Hayward. 1991. The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J. Virol. 65: 3839-3852.
23. Chiou, C. J., J. Zong, I. Waheed, and G. S. Hayward. 1993. Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J. Virol. 67: 6201-6214.
24. Klucher, K. M., M. Sommer, J. T. Kadonaga, and D. H. Spector. 1993. In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Mol. Cell. Biol. 13: 1238-1250.
25. Schwartz, R., M. H. Sommer, A. Scully, and D. H. Spector. 1994. Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter. J. Virol. 68: 5613-5622.
26. Castillo, J. P., F. M. Frame, H. A. Rogoff, M. T. Pickering, A. D. Yurochko, and T. F. Kowalik. 2005. Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response. J. Virol. 79: 11467-11475.
27. E, X., M. T. Pickering, M. Debatis, J. Castillo, A. Lagadinos, S.Wang, S. Lu, and T. F. Kowalik. 2011. An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus. PLoS Pathog. 7: e1001342.
28. Jackson, S. P., and J. Bartek. 2009. The DNA-damage response in human biology and disease. Nature 461: 1071-1078.
29. Shen, Y. H., B. Utama, J. Wang, M. Raveendran, D. Senthil, W. J. Waldman, J. D. Belcher, G. Vercellotti, D. Martin, B. M. Mitchelle, and X. L. Wang. 2004. Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ. Res. 94: 1310-1317.
30. Gaspar, M., and T. Shenk. 2006. Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc. Natl. Acad. Sci. USA 103: 2821-2826.
31. Luo, M. H., K. Rosenke, K. Czornak, and E. A. Fortunato. 2007. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)-and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 81: 1934-1950.
32. Li, R., J. Zhu, Z. Xie, G. Liao, J. Liu, M. R. Chen, S. Hu, C. Woodard, J. Lin, S. D. Taverna, et al. 2011. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10: 390-400.
33. E, X., G. Savidis, C. R. Chin, S. Wang, S. Lu, A. L. Brass, and T. F. Kowalik. 2014. A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication. J. Virol. 88: 2279-2290.
34. E, X., and T. F. Kowalik. 2014. The DNA damage response induced by infection with human cytomegalovirus and other viruses. Viruses 6: 2155-2185.
35. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
36. Cerboni, C., A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni. 2007. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 110: 606-615.
37. Soriani, A., A. Zingoni, C. Cerboni, M. L. Iannitto, M. R. Ricciardi, V. Di Gialleonardo, M. Cippitelli, C. Fionda, M. T. Petrucci, A. Guarini, et al. 2009. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
38. Ardolino, M., A. Zingoni, C. Cerboni, F. Cecere, A. Soriani, M. L. Iannitto, and A. Santoni. 2011. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Blood 117: 4778-4786.
39. Cerboni, C., C. Fionda, A. Soriani, A. Zingoni, M. Doria, M. Cippitelli, and A. Santoni. 2014. The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells. Front. Immunol. 4: 508.
40. Fionda, C., M. P. Abruzzese, A. Zingoni, A. Soriani, B. Ricci, R. Molfetta, R. Paolini, A. Santoni, and M. Cippitelli. 2015. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation. BMC Cancer 15: 17.
41. Ward, J., Z. Davis, J. DeHart, E. Zimmerman, A. Bosque, E. Brunetta, D. Mavilio, V. Planelles, and E. Barker. 2009. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 5: e1000613.
42. Richard, J., S. Sindhu, T. N. Pham, J. P. Belzile, and E. A. Cohen. 2010. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115: 1354-1363.
43. Vassena, L., E. Giuliani, G. Matusali, E. A. Cohen, and M. Doria. 2013. The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. J. Gen. Virol. 94: 2664-2669.
44. Azad, R. F., V. B. Driver, K. Tanaka, R. M. Crooke, and K. P. Anderson. 1993. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob. Agents Chemother. 37: 1945-1954.
45. Luganini, A., P. Caposio, M. Mondini, S. Landolfo, and G. Gribaudo. 2008. New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 protein activity. J. Appl. Microbiol. 105: 1791-1801.
46. Bruno, T., F. De Nicola, S. Iezzi, D. Lecis, C. D'Angelo, M. Di Padova, N. Corbi, L. Dimiziani, L. Zannini, C. Jekimovs, et al. 2006. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell 10: 473-486.
47. Smith, I. L., I. Taskintuna, F. M. Rahhal, H. C. Powell, E. Ai, A. J. Mueller, S. A. Spector, and W. R. Freeman. 1998. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch. Ophthalmol. 116: 178-185.
48. Murphy, E., D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M. A. Jarvis, G. Hahn, J. A. Nelson, R. M. Myers, and T. E. Shenk. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 100: 14976-14981.
49. Ryckman, B. J., M. A. Jarvis, D. D. Drummond, J. A. Nelson, and D. C. Johnson. 2006. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 80: 710-722.
50. Bronzini, M., A. Luganini, V. Dell'Oste, M. De Andrea, S. Landolfo, and G. Gribaudo. 2012. The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J. Virol. 86: 6875-6888.
51. Grazia Revello, M., F. Baldanti, E. Percivalle, A. Sarasini, L. De-Giuli, E. Genini, D. Lilleri, N. Labò, and G. Gerna. 2001. In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J. Gen. Virol. 82: 1429-1438.
52. Caposio, P., T. Musso, A. Luganini, H. Inoue, M. Gariglio, S. Landolfo, and G. Gribaudo. 2007. Targeting the NF-κB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virusinduced inflammatory response in infected endothelial cells. Antiviral Res. 73: 175-184.
53. Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59: 4375-4382.
54. Block, W. D., D. Merkle, K. Meek, and S. P. Lees-Miller. 2004. Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine. Nucleic Acids Res. 32: 1967-1972.
55. Gariano, G. R., V. Dell'Oste, M. Bronzini, D. Gatti, A. Luganini, M. De Andrea, G. Gribaudo, M. Gariglio, and S. Landolfo. 2012. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog. 8: e1002498.
56. Mercorelli, B., A. Luganini, G. Muratore, S. Massari, M. E. Terlizzi, O. Tabarrini, G. Gribaudo, G. Palù, and A. Loregian. 2014. The 6-aminoquinoloneWC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication. Antimicrob. Agents Chemother. 58: 6615-6626.
57. Rölle, A., M. Mousavi-Jazi, M. Eriksson, J. Odeberg, C. Söderberg-Nauclér, D. Cosman, K. Kärre, and C. Cerboni. 2003. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: upregulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J. Immunol. 171: 902-908.
58. Yadav, D., J. Ngolab, R. S. Lim, S. Krishnamurthy, and J. D. Bui. 2009. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFNg-induced microRNA. J. Immunol. 182: 39-43.
59. Soriani, A., M. L. Iannitto, B. Ricci, C. Fionda, G. Malgarini, S. Morrone, G. Peruzzi, M. R. Ricciardi, M. T. Petrucci, M. Cippitelli, and A. Santoni. 2014. Reactive oxygen species-and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1. J. Immunol. 193: 950-960.
60. Solecki, D., S. Schwarz, E. Wimmer, M. Lipp, and G. Bernhardt. 1997. The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity. J. Biol. Chem. 272: 5579-5586.
61. Jupp, R., S. Hoffmann, A. Depto, R. M. Stenberg, P. Ghazal, and J. A. Nelson. 1993. Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J. Virol. 67: 5595-5604.
62. Cerboni, C., M. Mousavi-Jazi, A. Linde, K. Söderström, M. Brytting, B. Wahren, K. Kärre, and E. Carbone. 2000. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J. Immunol. 164: 4775-4782.
63. Tyms, A. S., J. M. Davis, J. R. Clarke, and D. J. Jeffries. 1987. Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth. J. Gen. Virol. 68: 1563-1573.
64. Jupp, R., S. Hoffmann, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1993. Human cytomegalovirus IE86 protein interacts with promoter-bound TATAbinding protein via a specific region distinct from the autorepression domain. J. Virol. 67: 7539-7546.
65. Arlt, H., D. Lang, S. Gebert, and T. Stamminger. 1994. Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J. Virol. 68: 4117-4125.
66. Bresnahan, W. A., T. Albrecht, and E. A. Thompson. 1998. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J. Biol. Chem. 273: 22075-22082.
67. Bennett, N. J., O. Ashiru, F. J. Morgan, Y. Pang, G. Okecha, R. A. Eagle, J. Trowsdale, J. G. Sissons, andM. R.Wills. 2010. Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. J. Immunol. 185: 1093-1102.
68. Chalupny, N. J., A. Rein-Weston, S. Dosch, and D. Cosman. 2006. Downregulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 346: 175-181.
69. Wilkinson, G. W., A. J. Davison, P. Tomasec, C. A. Fielding, R. Aicheler, I. Murrell, S. Seirafian, E. C. Wang, M. Weekes, P. J. Lehner, et al. 2015. Human cytomegalovirus: taking the strain. Med. Microbiol. Immunol. (Berl.) 204: 273-284.
70. Eagle, R. A., J. A. Traherne, O. Ashiru, M. R. Wills, and J. Trowsdale. 2006. Regulation of NKG2D ligand gene expression. Hum. Immunol. 67: 159-169.
71. Choy, M. K., and M. E. Phipps. 2010. MICA polymorphism: biology and importance in immunity and disease. Trends Mol. Med. 16: 97-106.
72. Cox, S. T., J. A. Madrigal, and A. Saudemont. 2014. Diversity and characterization of polymorphic 59 promoter haplotypes of MICA and MICB genes. Tissue Antigens 84: 293-303.
73. Luo, J., W. Tian, F. Pan, X. Liu, and L. Li. 2014. Allelic and haplotypic diversity of 5'promoter region of the MICA gene. Hum. Immunol. 75: 383-388.
74. Tomasec, P., E. C. Wang, A. J. Davison, B. Vojtesek, M. Armstrong, C. Griffin, B. P. McSharry, R. J. Morris, S. Llewellyn-Lacey, C. Rickards, et al. 2005. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6: 181-188.
75. Prod'homme, V., D. M. Sugrue, R. J. Stanton, A. Nomoto, J. Davies, C. R. Rickards, D. Cochrane, M. Moore, G. W. Wilkinson, and P. Tomasec. 2010. Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. J. Gen. Virol. 91: 2034-2039.
76. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderías, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirusinfected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
77. Martinet, L., L. Ferrari De Andrade, C. Guillerey, J. S. Lee, J. Liu, F. Souza-Fonseca-Guimaraes, D. S. Hutchinson, T. B. Kolesnik, S. E. Nicholson, N. D. Huntington, and M. J. Smyth. 2015. DNAM-1 expression marks an alternative program of NK cell maturation. Cell Rep. 11: 85-97.
78. Tokuyama, M., C. Lorin, F. Delebecque, H. Jung, D. H. Raulet, and L. Coscoy. 2011. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathog. 7: e1002265.
79. Venkataraman, G. M., D. Suciu, V. Groh, J. M. Boss, and T. Spies. 2007. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178: 961-969.
80. Sowmya, P., and H. N. Madhavan. 2009. Analysis of mixed infections by multiple genotypes of human cytomegalovirus in immunocompromised patients. J. Med. Virol. 81: 861-869.
81. Renzette, N., L. Gibson, J. D. Jensen, and T. F. Kowalik. 2014. Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections. Curr. Opin. Virol. 8: 109-115.